Fang Chen

8PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 15, 2026
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

Matthew Ho, Luca Paruzzo, Julia Han Noll

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

|Jun 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Stephen J Bagley, Arati S Desai, Joseph A Fraietta

|Jun 01, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Stephen J Bagley, Arati S Desai, Joseph A Fraietta

|Mar 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.

Stephen J Bagley, Meghan Logun, Joseph A Fraietta

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

Pageof 2

Frequent Collaborators

7 joint publications

Carl H June

6 joint publications

Donald L Siegel

5 joint publications

Wei-Ting Hwang

4 joint publications

Elizabeth O Hexner